ROIV- Roivant Sciences Ltd.
Roivant Sciences Ltd. (ROIV) has 15 insiders with recent SEC Form 4 filings, including 1 buy and 22 sells. ROIV is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 113.32M | $3.54B | - | |
| 10% | 33.65M | $1.05B | - | |
| Pres | 18.68M | $583.68M | - | |
| CEO | 16.74M | $523.00M | - | |
| Dir | 15.35M | $479.76M | - |
Activity
Buys and sells only
Transactions
10 filings · page 10
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | Venker Eric | President &COO | Sell | 24,037 | $8.02 | $192,776.74 | -3.2% | -12.7% | +38.5% | |
| Jan 3, 2023 | Venker Eric | President &COO | Sell | 119,245 | $7.46 | $889,030.88 | -6.9% | +3.5% | +51.9% | |
| Dec 9, 2022 | Venker Eric | President &COO | Sell | 145,105 | $7.03 | $1,019,736.28 | -7.1% | +9.9% | +40.4% | |
| Nov 10, 2022 | Dexcel Pharma Technologies Ltd.79 | 10% Owner | Buy | 4,000,000 | $5.00 | $20,000,000.00 | +4.0% | +48.5% | +70.1% | |
| Nov 10, 2022 | Svf Investments (uk) Ltd57 | 10% Owner | Sell | 4,343,919 | $4.75 | $20,633,615.25 | -4.4% | +48.5% | +70.1% | |
| Nov 10, 2022 | Gold Daniel Allen73 | Director | Sell | 5,656,081 | $4.75 | $26,866,384.75 | -4.4% | +48.5% | +70.1% | |
| Nov 10, 2022 | Qvt Financial LP74 | Director, 10% Owner, Director By Deputization | Sell | 5,656,081 | $4.75 | $26,866,384.75 | -4.4% | +48.5% | +70.1% | |
| Nov 10, 2022 | Manchester Keith S49 | Director | Sell | 3,922,504 | $4.75 | $18,631,894.00 | -4.4% | +48.5% | +70.1% | |
| Oct 25, 2022 | Gline Matthew | CEO | Sell | 19,276 | $4.40 | $84,814.40 | -1.6% | +77.8% | +78.7% | |
| Oct 25, 2022 | Kumar Rakhi45 | Chief Accounting Officer | Sell | 1,588 | $4.40 | $6,987.20 | -1.1% | +77.8% | +78.7% |